Channel-inactivating mutations and their revertant mutants in the envelope protein of infectious bronchitis virus

Journal of Virology

Volumn 91, Issue 5, 2017, Pages

  To, Janet ^a   Surya, Wahyu ^a   Fung, To Sing ^a   Li, Yan ^a   Verdià Bàguena, Carmina ^b   Queralt Martin, Maria ^b   Aguilella, Vicente M ^b   Liu, Ding Xiang ^a   Torres, Jaume ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b UNIVERSITAT JAUME I   (Spain)

Author keywords

Channel activity; Coronavirus; Envelope protein; Infectious bronchitis virus; NMR structure; Small membrane protein

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS VACCINE; ION CHANNEL;

ALLOSTERISM; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GAMMACORONAVIRUS; GENE MUTATION; GENETIC STABILITY; LIPID BILAYER; MICELLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; VIRION; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHICKEN; CHLOROCEBUS AETHIOPS; CONSERVED SEQUENCE; GENETICS; MEMBRANE POTENTIAL; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN MULTIMERIZATION; VERO CELL LINE; VIRUS RELEASE;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; CHICKENS; CONSERVED SEQUENCE; INFECTIOUS BRONCHITIS VIRUS; ION CHANNELS; MEMBRANE POTENTIALS; MUTATION; PROTEIN MULTIMERIZATION; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS RELEASE;

EID: 85013867369     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02158-16     Document Type: Article

References (72)

1. Beaudette FR, Hudson CB. 1937. Cultivation of the virus of infectious bronchitis. J Am Vet Med Assoc 90:51-60.
2. Sjaak de Wit JJ, Cook JKA, van der Heijden HMJF. 2011. Infectious bronchitis virus variants: a review of the history, current situation and control measures. Avian Pathol 40:223-235. https://doi.org/10.1080/03079457.2011.566260.
3. McMartin DA. 1993 Infectious bronchitis, p 249-274. In McFerran JB, McNulty MS (ed), Virus infections of birds. Elsevier Science Publishers, Amsterdam, the Netherlands.
4. Enjuanes L, Brian D, Cavanagh D, Holmes K, Lai MMC, Laude H, Masters P, Rottier P, Siddell SG, Spaan WJM, Taguchi F, Talbot P. 2000. Coronaviridae, p 835-849. In van Regenmortel MHV, Fauquet CM, Bishop DHL, Carsten EB, Estes MK, Lemon SM, McGeoch DJ, ManiloffJ, Mayo MA, Pringle CR, Wickner RB (ed), Virus taxonomy: classification and nomenclature of viruses: seventh report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, CA.
5. Woo PCY, Lau SKP, Huang Y, Yuen KY. 2009. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med 234:1117-1127. https://doi.org/10.3181/0903-MR-94.
6. de Groot RJ, Cowley JA, Enjuanes L, Faaberg KS, Perlman S, Rottier PJM, Snijder EJ, Ziebuhr J, Gorbalenya AE. 2011. Coronaviridae. International Union of Microbiological Societies VDEAP, London, United Kingdom.
7. Holmes KV. 2003. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 111:1605-1609. https://doi.org/10.1172/JCI18819.
8. Raj VS, Osterhaus ADME, Fouchier RAM, Haagmans BL. 2014. MERS: emergence of a novel human coronavirus. Curr Opin Virol 5:58-62. https://doi.org/10.1016/j.coviro.2014.01.010.
9. Lou Z, Sun Y, Rao Z. 2014. Current progress in antiviral strategies. Trends Pharmacol Sci 35:86-102. https://doi.org/10.1016/j.tips.2013.11.006.
10. Kilianski A, Baker SC. 2014. Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors. Antiviral Res 101:105-112. https://doi.org/10.1016/j.antiviral.2013.11.004.
11. Kilianski A, Mielech AM, Deng X, Baker SC. 2013. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J Virol 87: 11955-11962. https://doi.org/10.1128/JVI.02105-13.
12. Wei YQ, Guo HC, Dong H, Wang HM, Xu J, Sun DH, Fang SG, Cai XP, Liu DX, Sun SQ. 2014. Development and characterization of a recombinant infectious bronchitis virus expressing the ectodomain region of S1 gene of H120 strain. Appl Microbiol Biotechnol 98:1727-1735. https://doi.org/10.1007/s00253-013-5352-5.
13. Lv L, Li X, Liu G, Li R, Liu Q, Shen H, Wang W, Xue C, Cao Y. 2014. Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus. J Vet Sci 15: 209-216. https://doi.org/10.4142/jvs.2014.15.2.209.
14. Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS. 2012. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med 18:1820-1826. https://doi.org/10.1038/nm.2972.
15. Enjuanes L, Nieto-Torres JL, Jimenez-Guardeno JM, DeDiego ML. 2011. Recombinant live vaccines to protect against the severe acute respiratory syndrome coronavirus, p 73-97. In Dormitzer PR, Mandt C, Rappuoli R (ed), Replicating vaccines: a new generation. BAID-Birkhäuser Advances in Infectious Diseases. Springer, Basel, Switzerland.
16. Jackwood MW. 2012. Review of infectious bronchitis virus around the world. Avian Dis 56:634-641. https://doi.org/10.1637/10227-043012-Review.1.
17. Heald-Sargent T, Gallagher T. 2012. Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses 4:557-580. https://doi.org/10.3390/v4040557.
18. Masters PS. 2006. The molecular biology of coronaviruses. Adv Virus Res 66:193-292. https://doi.org/10.1016/S0065-3527(06)66005-3.
19. Liao Y, Yuan Q, Torres J, Tam JP, Liu DX. 2006. Biochemical and functional characterization of the membrane association and membrane permeabilizing activity of the severe acute respiratory syndrome coronavirus envelope protein. Virology 349:264-275. https://doi.org/10.1016/j.virol.2006.01.028.
20. Tung FYT, Abraham S, Sethna M, Hung S-L, Sethna P, Hogue BG, Brian DA. 1992. The 9-kDa hydrophobic protein encoded at the 3' end of the porcine transmissible gastroenteritis coronavirus genome is membraneassociated. Virology 186:676-683. https://doi.org/10.1016/0042-6822(92)90034-M.
21. Corse E, Machamer CE. 2003. The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction. Virology 312: 25-34. https://doi.org/10.1016/S0042-6822(03)00175-2.
22. Raamsman MJB, Krijnse Locker J, De Hooge A, De Vries AAF, Griffiths G, Vennema H, Rottier PJM. 2000. Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J Virol 74:2333-2342. https://doi.org/10.1128/JVI.74.5.2333-2342.2000.
23. Lopez LA, Riffle AJ, Pike SL, Gardner D, Hogue BG. 2008. Importance of conserved cysteine residues in the coronavirus envelope protein. J Virol 82:3000-3010. https://doi.org/10.1128/JVI.01914-07.
24. Nieto-Torres JL, DeDiego ML, Alvarez E, Jimenez-Guardeno JM, Regla-Nava JA, Llorente M, Kremer L, Shuo S, Enjuanes L. 2011. Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein. Virology 415:69-82. https://doi.org/10.1016/j.virol.2011.03.029.
25. DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, Castaño-Rodriguez C, Perlman S, Enjuanes L. 2014. Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol 88: 913-924. https://doi.org/10.1128/JVI.02576-13.
26. DeDiego ML, Nieto-Torres JL, Jimenez-Guardeno JM, Regla-Nava JA, Alvarez E, Oliveros JC, Zhao J, Fett C, Perlman S, Enjuanes L. 2011. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog 7:e1002315. https://doi.org/10.1371/journal.ppat.1002315.
27. Jimenez-Guardeno JM, Regla-Nava JA, Nieto-Torres JL, DeDiego ML, Castano-Rodriguez C, Fernandez-Delgado R, Perlman S, Enjuanes L. 2015. Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine. PLoS Pathog 11:e1005215. https://doi.org/10.1371/journal.ppat.1005215.
28. Jimenez-Guardeno JM, Nieto-Torres JL, DeDiego ML, Regla-Nava JA, Fernandez-Delgado R, Castano-Rodriguez C, Enjuanes L. 2014. The PDZbinding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis. PLoS Pathog 10: e1004320. https://doi.org/10.1371/journal.ppat.1004320.
29. Verdia-Baguena C, Nieto-Torres JL, Alcaraz A, DeDiego ML, Torres J, Aguilella VM, Enjuanes L. 2012. Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. Virology 432:485-494. https://doi.org/10.1016/j.virol.2012.07.005.
30. Wilson L, Gage P, Ewart G. 2006. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication. Virology 353: 294-306. https://doi.org/10.1016/j.virol.2006.05.028.
31. Torres J, Maheswari U, Parthasarathy K, Ng LF, Liu DX, Gong XD. 2007. Conductance and amantadine binding of a pore formed by a lysineflanked transmembrane domain of SARS coronavirus envelope protein. Protein Sci 16:2065-2071. https://doi.org/10.1110/ps.062730007.
32. Nieto-Torres JL, DeDiego ML, Verdia-Baguena C, Jimenez-Guardeno JM, Regla-Nava JA, Fernandez-Delgado R, Castano-Rodriguez C, Alcaraz A, Torres J, Aguilella VM, Enjuanes L. 2014. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog 10:e1004077. https://doi.org/10.1371/journal.ppat.1004077.
33. Parthasarathy K, Ng L, Lin X, Liu DX, Pervushin K, Gong X, Torres J. 2008. Structural flexibility of the pentameric SARS coronavirus envelope protein ion channel. Biophys J 95:L39-41. https://doi.org/10.1529/biophysj.108.133041.
34. Torres J, Parthasarathy K, Lin X, Saravanan R, Kukol A, Ding XL. 2006. Model of a putative pore: the pentameric α-helical bundle of SARS coronavirus E protein in lipid bilayers. Biophys J 91:938-947. https://doi.org/10.1529/biophysj.105.080119.
35. Pervushin K, Tan E, Parthasarathy K, Xin L, Jiang FL, Yu D, Vararattanavech A, Soong TW, Liu DX, Torres J. 2009. Structure and inhibition of the SARS coronavirus envelope protein ion channel. PLoS Pathog 5:e1000511. https://doi.org/10.1371/journal.ppat.1000511.
36. Torres J, Wang J, Parthasarathy K, Liu DX. 2005. The transmembrane oligomers of coronavirus protein E. Biophys J 88:1283-1290. https://doi.org/10.1529/biophysj.104.051730.
37. Acevedo A, Brodsky L, Andino R. 2014. Mutational and fitness landscapes of an RNA virus revealed through population sequencing. Nature 505: 686-690. https://doi.org/10.1038/nature12861.
38. Ruch TR, Machamer CE. 2011. The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus. J Virol 85:675-685. https://doi.org/10.1128/JVI.01570-10.
39. Ruch TR, Machamer CE. 2012. A single polar residue and distinct membrane topologies impact the function of the infectious bronchitis coronavirus E protein. PLoS Pathog 8:e1002674. https://doi.org/10.1371/journal.ppat.1002674.
40. Lavi E, Wang Q, Weiss SR, Gonatas NK. 1996. Syncytia formation induced by coronavirus infection is associated with fragmentation and rearrangement of the Golgi apparatus. Virology 221:325-334. https://doi.org/10.1006/viro.1996.0382.
41. Ulasli M, Verheije MH, de Haan CAM, Reggiori F. 2010. Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell Microbiol 12:844-861. https://doi.org/10.1111/j.1462-5822.2010.01437.x.
42. Ruch TR, Machamer CE. 2012. The coronavirus E protein: assembly and beyond. Viruses 4:363-382. https://doi.org/10.3390/v4030363.
43. Corse E, Machamer CE. 2000. Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J Virol 74:4319-4326. https://doi.org/10.1128/JVI.74.9.4319-4326.2000.
44. Parthasarathy K, Lu H, Surya W, Vararattanavech A, Pervushin K, Torres A. 2012. Expression and purification of coronavirus envelope proteins using a modified beta-barrel construct. Protein Expr Purif 85:133-141. https://doi.org/10.1016/j.pep.2012.07.005.
45. Li Y, Surya W, Claudine S, Torres J. 2014. Structure of a conserved Golgi complex-targeting signal in coronavirus envelope proteins. J Biol Chem 289:12535-12549. https://doi.org/10.1074/jbc. M114.560094.
46. Surya W, Li Y, Verdià-Bàguena C, Aguilella VM, Torres J. 2015. MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels. Virus Res 201:61-66. https://doi.org/10.1016/j.virusres.2015.02.023.
47. Kall L, Krogh A, Sonnhammer EL. 2007. Advantages of combined transmembrane topology and signal peptide prediction-the Phobius web server. Nucleic Acids Res 35:W429-432. https://doi.org/10.1093/nar/gkm256.
48. Yuan Q, Liao Y, Torres J, Tam JP, Liu DX. 2006. Biochemical evidence for the presence of mixed membrane topologies of the severe acute respiratory syndrome coronavirus envelope protein expressed in mammalian cells. FEBS Lett 580:3192-3200. https://doi.org/10.1016/j.febslet.2006.04.076.
49. Torres J, Surya W, Li Y, Liu DX. 2015. Protein-protein interactions of viroporins in coronaviruses and paramyxoviruses: new targets for antivirals? Viruses 7:2858-2883. https://doi.org/10.3390/v7062750.
50. Westerbeck JW, Machamer CE. 2015. A coronavirus E protein is present in two distinct pools with different effects on assembly and the secretory pathway. J Virol 89:9313-9323. https://doi.org/10.1128/JVI.01237-15.
51. Surya W, Samsó M, Torres J. 2013. Structural and functional aspects of viroporins in human respiratory viruses: respiratory syncytial virus and coronaviruses, p 47-76. In Vats M (ed), Respiratory disease and infection-a new insight. InTech, Rijeka, Croatia. https://doi.org/10.5772/53957.
52. To J, Surya W, Torres J. 2016. Targeting the ion channel activity of viroporins. In Donev R (ed), Advances in protein chemistry and structural biology: ion channels as therapeutic targets, part B, vol 104. Elsevier, Amsterdam, Netherlands.
53. OuYang B, Xie S, Berardi MJ, Zhao X, Dev J, Yu W, Sun B, Chou JJ. 2013. Unusual architecture of the p7 channel from hepatitis C virus. Nature 498:521-525. https://doi.org/10.1038/nature12283.
54. Ghosh A, Pithadia AS, Bhat J, Bera S, Midya A, Fierke CA, Ramamoorthy A, Bhunia A. 2015. Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP. Biochemistry 54: 2249-2261. https://doi.org/10.1021/acs.biochem.5b00061.
55. Fischer F, Stegen CF, Masters PS, SamsonoffWA. 1998. Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly. J Virol 72:7885-7894.
56. Corse E, Machamer CE. 2002. The cytoplasmic tail of infectious bronchitis virus E protein directs Golgi targeting. J Virol 76:1273-1284. https://doi.org/10.1128/JVI.76.3.1273-1284.2002.
57. Netland J, DeDiego ML, Zhao J, Fett C, Alvarez E, Nieto-Torres JL, Enjuanes L, Perlman S. 2010. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. Virology 399:120-128. https://doi.org/10.1016/j.virol.2010.01.004.
58. Lamirande EW, Dediego ML, Roberts A, Jackson JP, Alvarez E, Sheahan T, Shieh WJ, Zaki SR, Baric R, Enjuanes L, Subbarao K. 2008. A live attenuated SARS coronavirus is immunogenic and efficacious in golden Syrian hamsters. J Virol 82:7721-7724. https://doi.org/10.1128/JVI.00304-08.
59. Teoh KT, Siu YL, Chan WL, Schluter MA, Liu CJ, Peiris JS, Bruzzone R, Margolis B, Nal B. 2010. The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. Mol Biol Cell 21:3838-3852. https://doi.org/10.1091/mbc. E10-04-0338.
60. Regla-Nava JA, Nieto-Torres JL, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, Castaño-Rodríguez C, Perlman S, Enjuanes L, DeDiego ML. 2015. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. J Virol 89:3870-3887. https://doi.org/10.1128/JVI.03566-14.
61. Almazán F, DeDiego ML, Sola I, Zuñiga S, Nieto-Torres JL, Marquez-Jurado S, Andrés G, Enjuanes L. 2013. Engineering a replicationcompetent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBio 4:e00650-13. https://doi.org/10.1128/mBio.00650-13.
62. Ng LFP, Liu DX. 1998. Identification of a 24-kDa polypeptide processed from the coronavirus infectious bronchitis virus 1a polyprotein by the 3C-like proteinase and determination of its cleavage sites. Virology 243:388-395. https://doi.org/10.1006/viro.1998.9058.
63. Fang S, Chen B, Tay FPL, Ng BS, Liu DX. 2007. An arginine-to-proline mutation in a domain with undefined functions within the helicase protein (Nsp13) is lethal to the coronavirus infectious bronchitis virus in cultured cells. Virology 358:136-147. https://doi.org/10.1016/j.virol.2006.08.020.
64. Liu DX, Inglis SC. 1991. Association of the infectious bronchitis virus 3c protein with the virion envelope. Virology 185:911-917. https://doi.org/10.1016/0042-6822(91)90572-S.
65. Li Q, Xiao H, Tam JP, Liu DX. 2006. Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus by interaction with Ubc9. Adv Exp Med Biol 581:121-126. https://doi.org/10.1007/978-0-387-33012-9_21.
66. Marley J, Lu M, Bracken C. 2001. A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR 20:71-75. https://doi.org/10.1023/A:1011254402785.
67. Bezrukov SM, Vodyanoy I. 1993. Probing alamethicin channels with water-soluble polymers-effect on conductance of channel states. Biophys J 64:16-25. https://doi.org/10.1016/S0006-3495(93)81336-5.
68. Montal M, Mueller P. 1972. Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proc Natl Acad of Sci U S A 69:3561-3566. https://doi.org/10.1073/pnas.69.12.3561.
69. Gan SW, Vararattanavech A, Nordin N, Eshaghi S, Torres J. 2011. A cost-effective method for simultaneous homo-oligomeric size determination and monodispersity conditions for membrane proteins. Anal Biochem 416:100-106. https://doi.org/10.1016/j.ab.2011.05.007.
70. Shen Y, Delaglio F, Cornilescu G, Bax A. 2009. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomolecular NMR 44:213-223. https://doi.org/10.1007/s10858-009-9333-z.
71. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567-580. https://doi.org/10.1006/jmbi.2000.4315.
72. Combet C, Blanchet C, Geourjon C, Deleage G. 2000. NPS@: network protein sequence analysis. Trends Biochem Sci 25:147-150. https://doi.org/10.1016/S0968-0004(99)01540-6.